| Prev Close | 1.19 |
| Day Low/High | 0.00 / 0.00 |
| 52 Wk Low/High | 0.96 / 3.00 |
| Avg Volume | 517.20K |
| Exchange | NASDAQ |
| Shares Outstanding | 46.14M |
| Market Cap | 61.37M |
| EPS | -0.30 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
Putting 2 Biotechs Under the Microscope
These low-dollar biotech stocks are making big moves Monday -- in opposite directions.
Complete Response Letter For REMOXY®
Company Will Host Conference Call Monday, September 26th at 9:00am EDT
DURECT Provides REMOXY® Update
Pain Therapeutics Announced today that an FDA Advisory Committee Meeting for REMOXY® is Not Needed and No Change to September 25, 2016 PDUFA Date
Pain Therapeutics Announces Advisory Committee Meeting For REMOXY® Is Not Needed
No Change to September 25th PDUFA Date
DURECT Announces FDA Advisory Committee Meeting For REMOXY®
FDA's Tentative Date for Advisory Committee Meeting is August 5, 2016 and No Change to PDUFA Date of September 25, 2016
Pain Therapeutics Resubmits REMOXY New Drug Application To The U.S. Food And Drug Administration
REMOXY NDA Has Priority Review
Pain Therapeutics Reports 2015 Financial Results And Corporate Update
Focus in 2016 Will be on REMOXY, Fiscal Discipline and Advancing Pipeline
Pain Therapeutics Reports Q3 2015 Financial Results And Update On REMOXY
Focus Remains on NDA Resubmission to FDA, Targeted for Q1 2016
Short Interest In Pain Therapeutics Makes 27.2% Move
The most recent short interest data has been released by the NASDAQ for the 05/29/2015 settlement date, which shows a 650,044 share increase in total short interest for Pain Therapeutics Inc , to 3,037,711, an increase of 27.23% since 05/15/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Pain Therapeutics Announces Update On Drug Portfolio
Conference Call Tomorrow, Tuesday, at 4:30 p.m. Eastern Time
Short Interest Decreases By 20% For PTIE
The most recent short interest data has been released by the NASDAQ for the 10/31/2014 settlement date, which shows a 383,304 share decrease in total short interest for Pain Therapeutics Inc , to 1,544,923, a decrease of 19.88% since 10/15/2014. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Pain Therapeutics Reports Q3 2014 Financial Results
Conference Call Today at 3:30 p.m. CT/4:30 pm ET
Pfizer (PFE) Stock Falls After Dropping Pain Drug
Shares of Pfizer (PFE) are down after the pharmaceutical company decided to discontinue its agreement to develop and commercialize the drug Remoxy, an oral formulation of oxycodone.